VOR
Vor Biopharma Inc
$1.92
Earnings Summary
Revenue | $0Mn |
Net Profits | $-33.19Mn |
Net Profit Margins | -Inf% |
Highlights
Vor Biopharma Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q3 2023. On a quarterly growth basis, Vor Biopharma Inc has generated NaN% jump in its revenue since last 3-months.
Vor Biopharma Inc’s net profit fell -41.38% since last year same period to $-33.19Mn in the Q3 2023. On a quarterly growth basis, Vor Biopharma Inc has generated -10.71% fall in its net profits since last 3-months.
Vor Biopharma Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q3 2023. On a quarterly growth basis, Vor Biopharma Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Vor Biopharma Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.5 |
EPS Estimate Current Year | -0.5 |
Highlights
Vor Biopharma Inc’s earning per share (EPS) estimates for the current quarter stand at -0.5 - a -6.38% fall from last quarter’s estimates.
Vor Biopharma Inc’s earning per share (EPS) estimates for the current year stand at -0.5.
Key Ratios
Key ratios of the Vor Biopharma Inc post its Q3 2023 earnings
Earning Per Share (EPS) | -0.49 |
Highlights
Vor Biopharma Inc’s earning per share (EPS) jumped 22.22% since last year same period to -0.49 in the Q3 2023. This indicates that the Vor Biopharma Inc has generated 22.22% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-07 | -0.47 | -0.49 | -4.26% |
2023-08-10 | -0.43 | -0.45 | -4.65% |
2023-05-11 | -0.38 | -0.43 | -13.16% |
₹0 US Stocks a/c Opening Fee